Table 1 Clinical information about sepsis patients in the survivor and non-survivor groups
From: Potential roles of vitamin D binding protein in attenuating liver injury in sepsis
Clinical data | Sepsis survivor group (n = 43) | Sepsis non-survivor group (n = 35) | P |
|---|---|---|---|
Age (year, mean ± SD) | 49.7 ± 22.0 | 71.6 ± 14.4 |  < 0.001 |
Gender (male/female) | 29/14 | 27/8 |  > 0.05 |
WBC (× 109/L, mean ± SD) | 13.6 ± 6.0 | 13.1 ± 6.9 |  > 0.05 |
CRP (mg/dl, mean ± SD) | 11.1 ± 7.7 | 10.1 ± 6.3 |  > 0.05 |
Ca2+ (mmol/L, mean ± SD) | 2.077 ± 0.261 | 2.012 ± 0.268 |  > 0.05 |
TP (g/L, mean ± SD) | 56.457 ± 13.521 | 54.963 ± 10.155 |  > 0.05 |
PHOS (mmol/L, mean ± SD) | 0.949 ± 0.357 | 0.993 ± 0.619 |  > 0.05 |
ALB (g/L, mean ± SD) | 30.9 ± 8.2 | 30.3 ± 5.5 |  > 0.05 |
SOFA score (mean ± SD) | 5.5 ± 3.7 | 10.7 ± 7.3 |  < 0.001 |
APACHE II score (mean ± SD) | 15.6 ± 6.3 | 24.9 ± 7.4 |  < 0.001 |
VDBP(μg/ml, mean ± SD) | 295.2 ± 52.9 | 178.1 ± 30.6 |  < 0.001 |
25(OH)D3 (nmol/L, mean ± SD) | 26.2 ± 12.7 | 19.6 ± 12.6 | 0.0247 |
1,25(OH)2D3 (fmol/L, mean ± SD) | 8106.0 ± 4952.1 | 5852.7 ± 2040.4 | 0.0138 |